Openbookopenbook
Equity
Herborium Group Inc(HBRM)
USD --+0.00%
Reward48Moderate
Risk65Medium-High
📊75%Data
Strong 26% profit margin · Revenue growing 23% YoY
HBRM
+0.0 · +0.00%
USD · PINK
Herborium Group Inc | Healthcare
Value Trap
Market Cap:1.09M
ℹ️
Reward Rating
48
Moderate
Bottom 25% (model universe)
75% data coverage
ℹ️
Risk Rating
65
Medium-High
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on HBRM to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Herborium Group Inc?

, a botanical therapeutics company, develops, licenses, and markets proprietary, botanical based medicinal products to consumers and healthcare professionals.

HBRM · Verdict

Moderate reward · elevated risk

HBRM stands out on valuation and cash flow, but watch the volatility signal.

Based on 88% data coverage

HBRM · Verdict

What’s working & what to watch

Strengths 2

  • Valuation75/100

    Above average

  • Cash flow69/100

    35% free-cash-flow margin

Watchouts 3

  • Volatility5/100

    Weak vs peers

  • Balance sheet33/100

    Current ratio 0.01

  • Growth35/100

    Rev +0.0% CAGR · earnings +0.0%

Model-based scoring. For information only — not financial advice.

What is Herborium Group Inc?

, a botanical therapeutics company, develops, licenses, and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The company offers dermatology products, which include AcnEase, an herbal medicinal product for enhancing conditions associated with hormonal acne and multiple symptoms of Rosacea; and AcnEase Skin Management System for the treatment of acne marks/scars. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 1.09M.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Profitability metrics are mixed — margins may be under pressure.
⚠️ Risk
Moderate volatility with meaningful macro and earnings sensitivity.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (48)

The scoring profile indicates limited reward potential at this time, with valuation and momentum offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap1.09M
P/E RatioN/A
Dividend YieldN/A
52 Week High0.0001
52 Week LowN/A
Last AnnualNovember
IPO DateN/A
IncorporatedUSA
Shares Outstanding11B
No. of Employees2
IndustryDrug Manufacturers - Specialty & Generic
ExchangePINK
Beta8.811
CurrencyUSD
Websitewww.herborium.com
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.